| Literature DB >> 24669243 |
Yong He1, Amans Coonar2, Sabin Gelvez-Zapata2, Post Sastry2, Archer Page2.
Abstract
At present, there is increasing interest in surgical procedures using a robot-assisted device. The aim of this study was to investigate whether robot-assisted video-assisted thoracoscopic surgery (VATS) was more effective than conventional VATS. A total of 64 VATS lobectomies in Papworth Hospital (Cambridge, UK) were included in the study. In 34 cases the lobectomies were performed using conventional VATS (CV group), while in the remaining 30 cases the lobectomies were performed using robot-assisted VATS (Robotic group). In the robot-assisted VATS, FreeHand®, a thoracoscopic camera controller produced by Freehand 2010 Ltd. (Eastleigh, UK), was used. The duration of the thoracoscopic surgery in the Robotic group was 145.50±10.43 min, whereas in the CV group the duration was 162.79±9.40 min. The surgery duration in the Robotic group was 10.62% shorter than that in the CV group (P<0.05). The rates of bleeding, pulmonary infection, arrhythmia and prolonged air leak (≥5 days) in the Robotic group were 0, 3.33, 26.67 and 13.33%, respectively, while the corresponding rates in the CV group were 2.94, 5.88, 20.59 and 17.65%, respectively. No significant differences were identified in the postoperative complication rates between the two groups (P≥0.05). There was no perioperative mortality in the study. Compared with conventional VATS, FreeHand-assisted VATS provides a similar rate of postoperative complications and a reduced surgery duration, and may be beneficial for the recovery of the patients following VATS.Entities:
Keywords: FreeHand; robot-assisted video-assisted thoracoscopic surgery; thoracoscopic camera holders
Year: 2014 PMID: 24669243 PMCID: PMC3961121 DOI: 10.3892/etm.2014.1532
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447
Analysis of the preoperative concurrent diseases in the two groups.
| Disease | Robotic group % (n) | CV group % (n) | χ2 | P-value |
|---|---|---|---|---|
| Heart disease | 36.67 (11/30) | 38.24 (13/34) | 0.017 | 0.897 |
| Emphysema | 26.67 (8/30) | 20.59 (7/34) | 0.328 | 0.567 |
| Diabetes | 20.00 (6/30) | 20.59 (7/34) | 0.003 | 0.953 |
Robotic group, robot-assisted video-assisted thoracoscopic surgery (VATS); CV group, conventional VATS.
Figure 1The FreeHand device (Freehand 2010, Ltd., Eastleigh, UK), which is suitable for use in all thoracoscopic procedures. FreeHand consists of the following components: Control box, arm, hands-free control unit, indicator unit and foot pedal, as well as a sterile, single-use pack and a Freehand storage cart.
Analysis of the postoperative complications in the two groups.
| Complication | Robotic group % (n) | CV group % (n) | χ2 | P-value |
|---|---|---|---|---|
| Bleeding | 0 (0/30) | 2.94 (1/34) | 0.896 | 0.344 |
| Pulmonary infection | 3.33 (1/30) | 5.88 (2/34) | 0.232 | 0.630 |
| Arrhythmia | 26.67 (8/30) | 20.59 (7/34) | 0.328 | 0.567 |
| Prolonged air leak | 13.33 (4/30) | 17.65 (6/34) | 0.225 | 0.635 |
There was no perioperative mortality among the cases. Robotic group, robot-assisted video-assisted thoracoscopic surgery (VATS); CV group, conventional VATS.
Figure 2The rates of postoperative complications were similar in the two groups. In the Robotic group, the rates of bleeding, pulmonary infection, arrhythmia and prolonged air leak (≥5 days) were 0, 3.33, 26.67 and 13.33%, respectively. In the CV group, the rates of the corresponding complications were 2.94, 5.88, 20.59 and 17.65%, respectively. No significant differences were identified between the two groups (P≥0.05). Robotic group, robot-assisted video-assisted thoracoscopic surgery (VATS); CV group, conventional VATS.
Analysis of the average thoracoscopic surgery duration (min) in the two groups.
| Robotic group | CV group | P-value |
|---|---|---|
| 145.50±10.43 | 162.79±9.40 | 0.016 |
Robotic group, robot-assisted video-assisted thoracoscopic surgery (VATS); CV group, conventional VATS.